SEQENS

Scientific Communication Manager at SEQENS Innovative BU – CRDO. SEQENS is a worldwide leader in the development and production of active ingredients, pharmaceutical intermediates and specialty ingredients 

Juliette graduated her doctorate in organic chemistry at the University of Caen (France), in the field of organocatalysis and asymmetric synthesis. She then followed an Industrial Post-doctoral fellowship at Zeneca Life Science Molecules in UK in homogeneous and heterogeneous catalysis. Integrated into the R&D department, she focused on developing new technology platforms in chemo- and bio-catalysis at Avecia – CDMO (Contract Development Manufacturing Organization) in Huddersfield (UK). Besides, she co-wrote a chapter in « Asymmetric Catalysis on Industrial Scale », Wiley-VCH. She also involved through the UK national organization “Innovative Manufacture Initiative” for investigating new technical tools to speed up efficiency through R&D projects. 

Back to France, she had several R&D process development positions within PPG-Sipsy (now Zach System) and PCAS (now SEQENS). She was appointed R&D Manager on one of the industrial site at PCAS (now SEQENS) focusing on process development of some key technologies, including polymers for controlled drug release and was Head of Biocatalysis for Pharmaceutical Synthesis. She supervised Protéus (a protein science company integrated in SEQENS) as General Manager. 

Today, she values 25 years’ experience in the field of synthetic chemistry and industrial biocatalysis to leverage R&D network and bridge scientific communication gap between various area of chemistry and business. Juliette is author and co-author of more than 20 scientific articles.